MASIMO CORPMASIEarnings & Financial Report
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.
MASI Q3 FY2025 Key Financial Metrics
Revenue
$371.5M
Gross Profit
$230.6M
Operating Profit
$83.6M
Net Profit
$-100.4M
Gross Margin
62.1%
Operating Margin
22.5%
Net Margin
-27.0%
YoY Growth
-26.4%
EPS
$-1.84
MASIMO CORP Q3 FY2025 Financial Summary
MASIMO CORP reported revenue of $371.5M (down 26.4% YoY) for Q3 FY2025, with a net profit of $-100.4M (down 1124.5% YoY) (-27.0% margin). Cost of goods sold was $140.9M, operating expenses totaled $147.0M.
Key Financial Metrics
| Total Revenue | $371.5M |
|---|---|
| Net Profit | $-100.4M |
| Gross Margin | 62.1% |
| Operating Margin | 22.5% |
| Report Period | Q3 FY2025 |
MASIMO CORP Annual Revenue by Year
MASIMO CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.1B).
MASIMO CORP Quarterly Revenue & Net Profit History
MASIMO CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $371.5M | -26.4% | $-100.4M | -27.0% |
| Q2 FY2025 | $370.9M | -25.3% | $51.3M | 13.8% |
| Q1 FY2025 | $372.0M | -24.5% | $-170.7M | -45.9% |
| Q4 FY2024 | $600.7M | +9.4% | $-349.6M | -58.2% |
| Q3 FY2024 | $504.6M | +5.4% | $9.8M | 1.9% |
| Q2 FY2024 | $496.3M | +9.0% | $16.0M | 3.2% |
| Q1 FY2024 | $492.8M | -12.8% | $18.9M | 3.8% |
| Q4 FY2023 | $548.9M | -11.0% | $33.9M | 6.2% |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $548.9M | $492.8M | $496.3M | $504.6M | $600.7M | $372.0M | $370.9M | $371.5M |
| YoY Growth | -11.0% | -12.8% | 9.0% | 5.4% | 9.4% | -24.5% | -25.3% | -26.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.04B | $2.96B | $2.89B | $3.09B | $2.63B | $2.29B | $2.40B | $1.82B |
| Liabilities | $1.68B | $1.59B | $1.53B | $1.62B | $1.57B | $1.35B | $1.36B | $1.01B |
| Equity | $1.36B | $1.37B | $1.37B | $1.46B | $1.05B | $946.4M | $1.04B | $810.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $77.1M | $45.8M | $74.5M | $25.6M | $50.5M | $31.1M | $69.4M | $56.8M |